Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Taxane platinum combination chemotherapy versus single agent platinum for the first line treatment of epithelial ovarian cancer

This protocol has been withdrawn

Information

DOI:
https://doi.org/10.1002/14651858.CD010194.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 04 August 2015see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Nick Johnson

    Gynaecological Oncology, Royal United Hospital NHS Trust, Bath, UK

  • Tracie Miles

    Correspondence to: Gynaecological Oncology, Royal United Hospital NHS Trust, Bath, UK

    [email protected]

    [email protected]

  • Paul Cornes

    Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK

  • Edward Gilby

    Bath Clinic, Bath, UK

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • NIHR Cochrane Review Incentive Scheme 2012 ‐ award no. 11‐23‐N, UK.

Version history

Published

Title

Stage

Authors

Version

2015 Aug 04

Taxane platinum combination chemotherapy versus single agent platinum for the first line treatment of epithelial ovarian cancer

Protocol

Nick Johnson, Tracie Miles, Paul Cornes, Edward Gilby

https://doi.org/10.1002/14651858.CD010194.pub2

2012 Dec 12

Taxane‐platinum combination chemotherapy versus single agent platinum for the first‐line treatment of epithelial ovarian cancer

Protocol

Nick Johnson, Tracie Miles, Paul Cornes, Edward Gilby

https://doi.org/10.1002/14651858.CD010194